Shenzhen Salubris Pharmaceuticals Co., Ltd.

AG·尊龙凯时

Collaborating with global innovative resources,
studying pathogenic mechanisms, exploring treatment methods and developing innovative drugs

Scientific research topics

A new treatment of renal anemia

license-in SAL0951, an innovative drug for renal anemia

learn more

Efficient and collaborative R&D centers

Group Research Institute (Shenzhen)

Focusing on the discovery and development of small molecule innovative drugs, the institute has a highly talented R&D team led by returnees. We have built a sound medical development, operation, data management and statistics system, PV and quality a

R&D Institute (Chengdu)

Focusing on the research and development of innovative biologics and biosesimilars.; early discovery platforms: antibody screening and optimization, CHO-GS eukaryotic expression system, as well as complete CMC development system, including cell line

Group Research Institute (USA)

Located in Maryland, USA, it has gathered a number of well-known new drug experts, who devote themselves to the early research and development of innovative drugs and carry out research on new biopharmaceuticals with global independent intellectual p

R&D platform

learn more

R&D pipeline

learn more